Jill Carroll, Director at Avalyn Pharma Inc. (AVLN), bought 277,778 shares at $18.00 ($5.0M) on 2026-05-01, disclosed to the SEC on 2026-05-01.
Director Jill Carroll executed the largest insider purchase in Avalyn Pharma's history, buying $5M worth of shares at $18.00. This high conviction bet comes as the stock trades just 1.19% below its 52-week high, signaling potential upside.
Avalyn Pharma is currently trading at $29.84, sitting just 1.19% below its 52-week high of $30.20. The stock has also recovered 14.77% from its 52-week low of $26.00, indicating a strong year-to-date trend.
Nothing distinguishes this filing.
| Filing → |
| ACLX | SELL | 2023-06-02 | $15.3M | — | Filing → |
| ACLX | SELL | 2023-05-15 | $29.0M | — | Filing → |
| ACLX | BUY | 2022-02-09 | $25.0M | — | Filing → |